Johnson & Johnson (JNJ) Beats Q1 Expectations

Johnson & Johnson (JNJ) gained $0.30 to $100.85 in premarket trading after it reported fiscal-first quarter earnings. The world’s biggest maker of health care products handed in earnings of $1.56 per share on revenue of $17.37 billion, beating Wall Street estimates of $1.54 per share on revenue of $17.33 billion. “The company delivered strong underlying […] View the full post at: Johnson & Johnson (JNJ) Beats Q1 Expectations Related posts: Microsoft Reports Sharp Dip in Q1 Profits Banks ‘Stress Test’ Questions and Expectations JPMorgan Posts Better-than-Expected Results